Analytical Performance of the FreeStyle Libre 2 Glucose Sensor in Healthy Male Adults
Sensors · 2024
DOI: 10.3390/s24175769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sensors, 2024. Verfasst von Eva Fellinger und 4 weiteren Autor:innen. Beteiligte Einrichtung: NextGenerationEU, dtec.bw Project Smart Health Lab, University of the Bundeswehr Munich, 85579 Neubiberg, Germany. Hauptthemen laut MEDLINE: Blood Glucose, Blood Glucose Self-Monitoring. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universität der Bundeswehr München.
Abstract (Originalsprache)
Continuous Glucose Monitoring (CGM) not only can be used for glycemic control in chronic diseases (e.g., diabetes), but is increasingly being utilized by individuals and athletes to monitor fluctuations in training and everyday life. However, it is not clear how accurately CGM reflects plasma glucose concentration in a healthy population in the absence of chronic diseases. In an oral glucose tolerance test (OGTT) with forty-four healthy male subjects (25.5 ± 4.5 years), the interstitial fluid glucose (ISFG) concentration obtained by a CGM sensor was compared against finger-prick capillary plasma glucose (CPG) concentration at fasting baseline (T0) and 30 (T30), 60 (T60), 90 (T90), and 120 (T120) min post OGTT to investigate differences in measurement accuracy. The overall mean absolute relative difference (MARD) was 12.9% (95%-CI: 11.8–14.0%). Approximately 100% of the ISFG values were within zones A and B in the Consensus Error Grid, indicating clinical accuracy. A paired t-test revealed statistically significant differences between CPG and ISFG at all time points (T0: 97.3 mg/dL vs. 89.7 mg/dL, T30: 159.9 mg/dL vs. 144.3 mg/dL, T60: 134.8 mg/dL vs. 126.2 mg/dL, T90: 113.7 mg/dL vs. 99.3 mg/dL, and T120: 91.8 mg/dL vs. 82.6 mg/dL; p < 0.001) with medium to large effect sizes (d = 0.57–1.02) and with ISFG systematically under-reporting the reference system CPG. CGM sensors provide a convenient and reliable method for monitoring blood glucose in the everyday lives of healthy adults. Nonetheless, their use in clinical settings wherein implications are drawn from CGM readings should be handled carefully.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NextGenerationEU, dtec.bw Project Smart Health Lab, University of the Bundeswehr Munich, 85579 Neubiberg, Germany.
- Institute of Sport Sciences, University of the Bundeswehr Munich, 85579 Neubiberg, Germany.
- Research Center Smart Digital Health, University of the Bundeswehr Munich, 85579 Neubiberg, Germany.
ORCID-Profile: Eva Fellinger, Tom Brandt
Förderung
- Universität der Bundeswehr München
Zitieren
APA
Fellinger, E., Brandt, T., Creutzburg, J., Rommerskirchen, T., & Schmidt, A. (2024). Analytical Performance of the FreeStyle Libre 2 Glucose Sensor in Healthy Male Adults. Sensors. https://doi.org/10.3390/s24175769
Vancouver
Fellinger E, Brandt T, Creutzburg J, Rommerskirchen T, Schmidt A. Analytical Performance of the FreeStyle Libre 2 Glucose Sensor in Healthy Male Adults. Sensors. 2024. doi:10.3390/s24175769
BibTeX
@article{Fellinger2024,
author = {Fellinger, Eva and Brandt, Tom and Creutzburg, Justin and Rommerskirchen, Tessa and Schmidt, Annette},
title = {Analytical Performance of the FreeStyle Libre 2 Glucose Sensor in Healthy Male Adults},
journal = {Sensors},
year = {2024},
doi = {10.3390/s24175769}
}
EUVIMED